XORTX Therapeutics Inc (XRTX)
2.94
+0.35
(+13.51%)
USD |
NASDAQ |
Apr 26, 16:00
2.94
0.00 (0.00%)
After-Hours: 20:00
XORTX Therapeutics Cash from Operations (TTM): -8.754M for Sept. 30, 2023
Cash from Operations (TTM) Chart
Historical Cash from Operations (TTM) Data
Date | Value |
---|---|
September 30, 2023 | -8.754M |
June 30, 2023 | -8.650M |
March 31, 2023 | -8.798M |
December 31, 2022 | -8.818M |
September 30, 2022 | -8.451M |
June 30, 2022 | -7.498M |
March 31, 2022 | -6.332M |
December 31, 2021 | -4.755M |
September 30, 2021 | -0.5065M |
June 30, 2021 | -0.6135M |
March 31, 2021 | -0.0974M |
December 31, 2020 | -0.5712M |
September 30, 2020 | -1.800M |
June 30, 2020 | -1.667M |
March 31, 2020 | -1.504M |
December 31, 2019 | -0.1911M |
September 30, 2019 | -0.1436M |
June 30, 2019 | -0.3252M |
March 31, 2019 | -0.489M |
Date | Value |
---|---|
December 31, 2018 | -1.142M |
September 30, 2018 | |
June 30, 2018 | |
March 31, 2018 | |
December 31, 2017 | |
November 30, 2017 | |
September 30, 2017 | |
August 31, 2017 | -0.1304M |
May 31, 2017 | -0.1578M |
March 31, 2017 | -0.1239M |
February 28, 2017 | -0.1413M |
November 30, 2016 | -0.1273M |
August 31, 2016 | -0.15M |
May 31, 2016 | -0.1509M |
February 29, 2016 | -0.1286M |
November 30, 2015 | -0.2035M |
August 31, 2015 | -0.094M |
May 31, 2015 | -0.0837M |
February 28, 2015 | -0.0854M |
Cash From Operations Definition
Cash flow from operations is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall operating activities of the company. A few examples of operating activities include change in receivables, change in inventories, and changes in current assets.
Cash from Operations (TTM) Range, Past 5 Years
-8.818M
Minimum
Dec 2022
-0.0974M
Maximum
Mar 2021
-3.860M
Average
-1.734M
Median
Cash from Operations (TTM) Benchmarks
ImmunoPrecise Antibodies Ltd | -5.045M |
Acasti Pharma Inc | -13.57M |
Aurinia Pharmaceuticals Inc | -33.46M |
Edesa Biotech Inc | -6.252M |
Lexaria Bioscience Corp | -5.209M |